These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 6838322)

  • 1. Panic-induced elevation of plasma MHPG levels in phobic-anxious patients. Effects of clonidine and imipramine.
    Ko GN; Elsworth JD; Roth RH; Rifkin BG; Leigh H; Redmond DE
    Arch Gen Psychiatry; 1983 Apr; 40(4):425-30. PubMed ID: 6838322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma MHPG levels in lactate and isoproterenol anxiety states.
    Pohl R; Ettedgui E; Bridges M; Lycaki H; Jimerson D; Kopin I; Rainey JM
    Biol Psychiatry; 1987 Sep; 22(9):1127-36. PubMed ID: 3651531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Noradrenergic function and the mechanism of action of antianxiety treatment. II. The effect of long-term imipramine treatment.
    Charney DS; Heninger GR
    Arch Gen Psychiatry; 1985 May; 42(5):473-81. PubMed ID: 2985014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is buspirone effective for panic disorder?
    Sheehan DV; Raj AB; Sheehan KH; Soto S
    J Clin Psychopharmacol; 1990 Feb; 10(1):3-11. PubMed ID: 2407755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma MHPG in untreated panic disorder.
    Edlund MJ; Swann AC; Davis CM
    Biol Psychiatry; 1987 Dec; 22(12):1491-5. PubMed ID: 3676379
    [No Abstract]   [Full Text] [Related]  

  • 6. Noradrenergic function in panic anxiety. Effects of yohimbine in healthy subjects and patients with agoraphobia and panic disorder.
    Charney DS; Heninger GR; Breier A
    Arch Gen Psychiatry; 1984 Aug; 41(8):751-63. PubMed ID: 6742977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imipramine dose-response relationship in panic disorder with agoraphobia. Preliminary findings.
    Mavissakalian MR; Perel JM
    Arch Gen Psychiatry; 1989 Feb; 46(2):127-31. PubMed ID: 2643933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical response to clonidine and imipramine, and platelet alpha 2-adrenoreceptors in a case of agoraphobia with panic attacks.
    Zelnik TC; Garcia-Sevilla JA; Cameron OG; Smith CB
    Biol Psychiatry; 1982 Jun; 17(6):761-6. PubMed ID: 6285996
    [No Abstract]   [Full Text] [Related]  

  • 9. Noradrenergic neuronal dysregulation in panic disorder: the effects of intravenous yohimbine and clonidine in panic disorder patients.
    Charney DS; Woods SW; Krystal JH; Nagy LM; Heninger GR
    Acta Psychiatr Scand; 1992 Oct; 86(4):273-82. PubMed ID: 1333719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet alpha 2-adrenergic receptor binding and plasma catecholamines. Before and during imipramine treatment in patients with panic anxiety.
    Cameron OG; Smith CB; Hollingsworth PJ; Nesse RM; Curtis GC
    Arch Gen Psychiatry; 1984 Dec; 41(12):1144-8. PubMed ID: 6095785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Behavioral, neuroendocrine, and biochemical effects of 5-hydroxytryptophan administration in panic disorder.
    den Boer JA; Westenberg HG
    Psychiatry Res; 1990 Mar; 31(3):267-78. PubMed ID: 2139731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Normal urinary free cortisol and plasma MHPG in panic disorder: clinical and theoretical implications.
    Uhde TW; Joffe RT; Jimerson DC; Post RM
    Biol Psychiatry; 1988 Mar; 23(6):575-85. PubMed ID: 2833321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurobiological mechanisms of panic anxiety: biochemical and behavioral correlates of yohimbine-induced panic attacks.
    Charney DS; Woods SW; Goodman WK; Heninger GR
    Am J Psychiatry; 1987 Aug; 144(8):1030-6. PubMed ID: 3037926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of clonidine on anxiety disorders.
    Hoehn-Saric R; Merchant AF; Keyser ML; Smith VK
    Arch Gen Psychiatry; 1981 Nov; 38(11):1278-82. PubMed ID: 7305609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of a selective serotonin uptake inhibitor in agoraphobia with panic attacks. A double-blind comparison of zimeldine, imipramine and placebo.
    Evans L; Kenardy J; Schneider P; Hoey H
    Acta Psychiatr Scand; 1986 Jan; 73(1):49-53. PubMed ID: 2938422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diazepam and propranolol in panic disorder and agoraphobia.
    Noyes R; Anderson DJ; Clancy J; Crowe RR; Slymen DJ; Ghoneim MM; Hinrichs JV
    Arch Gen Psychiatry; 1984 Mar; 41(3):287-92. PubMed ID: 6367691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imipramine treatment of panic disorder in a boy with Tourette's syndrome.
    Sverd J
    J Clin Psychiatry; 1988 Jan; 49(1):31-2. PubMed ID: 3422074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alprazolam, imipramine and placebo treatment of panic disorder: predicting therapeutic response.
    Rosenberg R; Bech P; Mellergård M; Ottosson JO
    Acta Psychiatr Scand Suppl; 1991; 365():46-52. PubMed ID: 1862734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term effects of alprazolam and imipramine on cerebrospinal fluid monoamine metabolites and neuropeptides in panic disorder.
    Lepola U; Jolkkonen J; Rimón R; Riekkinen P
    Neuropsychobiology; 1989; 21(4):182-6. PubMed ID: 2483580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased anxiogenic effects of caffeine in panic disorders.
    Charney DS; Heninger GR; Jatlow PI
    Arch Gen Psychiatry; 1985 Mar; 42(3):233-43. PubMed ID: 2983630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.